IMA is loading

Main Financial Data 2000

Main Data: 31/12 Year 2000
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 294.79
– gross margin 137.20
– total operating cost 98.56
– net operating profit 35.37
– financial expenses, net 5.13
– net income before taxes 15.21

 

Consolidated balance sheet Millions/Euro
– operating capital 79.17
– fixed assets, net 100.90
– reserves and MLT non financial payables – 20.83
– net financial position 72.00
– stockholders’ equity 87.24

 

Other information Millions/Euro
– depreciation 12.74
– R & D expenses 17.81

 

  Euro
Dividend per share 0.23

 

  No.
Employees 2,121

 

  Lire
Shares outstanding 36,100,000,000

 

Main Data: 30/06 Year 2000
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 105.21
– gross margin 51.19
– total operating cost 50.56
– net operating profit 0.89
– financial expenses, net 2.22
– net income before taxes – 1.66

 

Consolidated balance sheet Millions/Euro
– operating capital 92.42
– fixed assets, net 89.44
– reserves and MLT non financial payables – 20.37
– net financial position – 91.33
– stockholders’ equity 70.15

 

Other information Millions/Euro
– depreciation 5.80
– R & D expenses 9.64

 

  No.
Employees 2,079

 

  Lire
Shares outstanding 36,100,000,000

 

Net Sales by Sector: Year 2000
  Millions/Euro  
tea, herbs & coffee 46.87 15.90%
pharmaceuticals packaging 238.49 80.90%
pharmaceuticals processing 9.43 3.20%
Total 294.79 100.00%

 

Net Sales by Country: Year 2000  
  Millions/Euro  
E.U. (excluding Italy) 96.16 32.62%
Other European countries 26.40 8.90%
North America 56.48 19.16%
Asia & Middle East 41.37 14.03%
Other countries 54.60 18.52%
Total exports 274.85 93.23%
Italy 19.95 6.77%
Total 294.80 100.00%